rs119480069
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_022436.3(ABCG5):c.1166G>A(p.Arg389His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000098 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000057 ( 0 hom. )
Consequence
ABCG5
NM_022436.3 missense
NM_022436.3 missense
Scores
7
7
5
Clinical Significance
Conservation
PhyloP100: 7.50
Genes affected
ABCG5 (HGNC:13886): (ATP binding cassette subfamily G member 5) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. The protein encoded by this gene functions as a half-transporter to limit intestinal absorption and promote biliary excretion of sterols. It is expressed in a tissue-specific manner in the liver, colon, and intestine. This gene is tandemly arrayed on chromosome 2, in a head-to-head orientation with family member ABCG8. Mutations in this gene may contribute to sterol accumulation and atheroschlerosis, and have been observed in patients with sitosterolemia. [provided by RefSeq, Jul 2008]
DYNC2LI1 (HGNC:24595): (dynein cytoplasmic 2 light intermediate chain 1) This gene encodes a protein that is a component of the dynein-2 microtubule motor protein complex that plays a role in the retrograde transport of cargo in primary cilia via the intraflagellar transport system. This gene is ubiquitously expressed and its protein, which localizes to the axoneme and Golgi apparatus, interacts directly with the cytoplasmic dynein 2 heavy chain 1 protein to form part of the multi-protein dynein-2 complex. Mutations in this gene produce defects in the dynein-2 complex which result in several types of ciliopathy including short-rib thoracic dysplasia 15 with polydactyly (SRTD15). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-43824071-C-T is Pathogenic according to our data. Variant chr2-43824071-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 4980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-43824071-C-T is described in Lovd as [Likely_pathogenic]. Variant chr2-43824071-C-T is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.18254992). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCG5 | NM_022436.3 | c.1166G>A | p.Arg389His | missense_variant | 9/13 | ENST00000405322.8 | NP_071881.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCG5 | ENST00000405322.8 | c.1166G>A | p.Arg389His | missense_variant | 9/13 | 1 | NM_022436.3 | ENSP00000384513.2 | ||
ABCG5 | ENST00000486512.5 | n.1687G>A | non_coding_transcript_exon_variant | 5/9 | 1 | |||||
ABCG5 | ENST00000409962.1 | n.1449G>A | non_coding_transcript_exon_variant | 5/9 | 2 | |||||
ABCG5 | ENST00000644754.1 | n.1550G>A | non_coding_transcript_exon_variant | 6/10 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152176Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
15
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251474Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135914
GnomAD3 exomes
AF:
AC:
38
AN:
251474
Hom.:
AF XY:
AC XY:
18
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 727244
GnomAD4 exome
AF:
AC:
83
AN:
1461886
Hom.:
Cov.:
32
AF XY:
AC XY:
40
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74474
GnomAD4 genome
AF:
AC:
15
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
18
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Sitosterolemia 2 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 19, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 30, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PP1+PP3+PM3_VeryStrong+PM2_Supporting - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Feb 08, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 28, 2021 | PS3, PS4, PM3 - |
ABCG5-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 02, 2024 | The ABCG5 c.1166G>A variant is predicted to result in the amino acid substitution p.Arg389His. This variant has been reported in multiple individuals with sitosterolemia and has been observed to segregate with disease in families (Lee et al. 2001. PubMed ID: 11138003; Niu et al. 2010. PubMed ID: 20521169; Tada et al. 2015. PubMed ID: 25665839; Yagasaki et al. 2017. PubMed ID: 28771437; Pek et al. 2018. PubMed ID: 29353225; Tada et al. 2018. PubMed ID: 30007774; Nomura et al. 2020. PubMed ID: 32862661; Reeskamp et al. 2020. PubMed ID: 32088153). This variant is reported in 0.21% of alleles in individuals of East Asian descent in gnomAD. This variant is interpreted as pathogenic. - |
Sitosterolemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 08, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 389 of the ABCG5 protein (p.Arg389His). This variant is present in population databases (rs119480069, gnomAD 0.2%). This missense change has been observed in individual(s) with sitosterolemia (PMID: 11138003, 15375183, 20521169, 20543520, 25665839, 28203044, 28771437, 30985648, 31060161). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It is commonly reported in individuals of Asian ancestry (PMID: 15375183, 30985648). ClinVar contains an entry for this variant (Variation ID: 4980). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 05, 2024 | The p.R389H pathogenic mutation (also known as c.1166G>A), located in coding exon 9 of the ABCG5 gene, results from a G to A substitution at nucleotide position 1166. The arginine at codon 389 is replaced by histidine, an amino acid with highly similar properties. This variant has been reported in the homozygous and compound heterozygous states in several individuals and families affected with sitosterolemia, being reported as a common cause of disease in Asian populations (Lee MH et al. Nat Genet, 2001 Jan;27:79-83; Wang J et al. J Lipid Res, 2004 Dec;45:2361-7; Niu DM et al. J Inherit Metab Dis, 2010 Aug;33:437-43; Tada H et al. JIMD Rep, 2015 Feb;21:115-22; Ono S et al. Clin Pediatr Endocrinol, 2017 Jan;26:17-23; Yagasaki H et al. J Pediatr Endocrinol Metab, 2017 Aug;30:1007-1011; Huang D et al. Medicine (Baltimore), 2019 Apr;98:e15013; Nomura A et al. Circ Genom Precis Med, 2020 10;13:417-423; Yamada Y et al. CJC Open, 2021 Aug;3:1085-1088). An in vitro study suggested this alteration may impact protein function (Graf GA et al. J Biol Chem, 2004 Jun;279:24881-8). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Pathogenic
Sift
Benign
T;.
Sift4G
Pathogenic
D;.
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at